XAIR Fundamental Analysis - BEYOND AIR INC

Name: BEYOND AIR INC (XAIR) Stock
Brand: BEYOND AIR INC
Rating: 3.5 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to XAIR. XAIR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. XAIR has a bad profitability rating. Also its financial health evaluation is rather negative. XAIR is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

XAIR had negative earnings in the past year.

XAIR had a negative operating cash flow in the past year.

In the past 5 years XAIR always reported negative net income.

In the past 5 years XAIR always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of XAIR (-149.80%) is worse than 86.77% of its industry peers.

Looking at the Return On Equity, with a value of -424.25%, XAIR is doing worse than 81.48% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-149.8%
ROE	-424.25%
ROIC	N/A

ROA(3y)-114.02%

ROA(5y)-88.4%

ROE(3y)-243.66%

ROE(5y)-173.09%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for XAIR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

XAIR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for XAIR has been increased compared to 1 year ago.

The number of shares outstanding for XAIR has been increased compared to 5 years ago.

Compared to 1 year ago, XAIR has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -18.30, we must say that XAIR is in the distress zone and has some risk of bankruptcy.

XAIR has a worse Altman-Z score (-18.30) than 87.83% of its industry peers.

XAIR has a Debt/Equity ratio of 0.97. This is a neutral value indicating XAIR is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.97, XAIR is doing worse than 75.66% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.97
Debt/FCF	N/A
Altman-Z	-18.3

ROIC/WACCN/A

WACC7.97%

2.3 Liquidity

A Current Ratio of 3.24 indicates that XAIR has no problem at all paying its short term obligations.

XAIR has a Current ratio of 3.24. This is in the better half of the industry: XAIR outperforms 63.49% of its industry peers.

XAIR has a Quick Ratio of 2.71. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.

With a decent Quick ratio value of 2.71, XAIR is doing good in the industry, outperforming 65.61% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.24
Quick Ratio	2.71

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

XAIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.09%, which is quite impressive.

Looking at the last year, XAIR shows a very strong growth in Revenue. The Revenue has grown by 219.67%.

Measured over the past years, XAIR shows a very strong growth in Revenue. The Revenue has been growing by 21.66% on average per year.

EPS 1Y (TTM)36.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%77.68%

Revenue 1Y (TTM)219.67%

Revenue growth 3YN/A

Revenue growth 5Y21.66%

Sales Q2Q%128.07%

3.2 Future

XAIR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.44% yearly.

The Revenue is expected to grow by 80.94% on average over the next years. This is a very strong growth

EPS Next Y77.15%

EPS Next 2Y37.06%

EPS Next 3Y25.67%

EPS Next 5Y15.44%

Revenue Next Year234.98%

Revenue Next 2Y190.44%

Revenue Next 3Y134%

Revenue Next 5Y80.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

XAIR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XAIR. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

XAIR's earnings are expected to grow with 25.67% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y37.06%

EPS Next 3Y25.67%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for XAIR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BEYOND AIR INC

NASDAQ:XAIR (11/13/2025, 2:00:45 PM)

1.505

+0.03 (+2.38%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)11-10 2025-11-10/amc

Earnings (Next)02-09 2026-02-09

Inst Owners10.53%

Inst Owner Change-17.61%

Ins Owners11.57%

Ins Owner Change0.07%

Market Cap8.08M

Revenue(TTM)3.71M

Net Income(TTM)-42.12M

Analysts82

Price Target10.71 (611.63%)

Short Float %3.22%

Short Ratio0.05

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)10.27%

Min EPS beat(2)-7.14%

Max EPS beat(2)27.68%

EPS beat(4)3

Avg EPS beat(4)7.99%

Min EPS beat(4)-7.14%

Max EPS beat(4)27.68%

EPS beat(8)6

Avg EPS beat(8)9.4%

EPS beat(12)7

Avg EPS beat(12)2.72%

EPS beat(16)8

Avg EPS beat(16)-9.4%

Revenue beat(2)0

Avg Revenue beat(2)-9.99%

Min Revenue beat(2)-18.64%

Max Revenue beat(2)-1.35%

Revenue beat(4)1

Avg Revenue beat(4)-8.05%

Min Revenue beat(4)-24.93%

Max Revenue beat(4)12.72%

Revenue beat(8)1

Avg Revenue beat(8)-18.99%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-6.25%

PT rev (3m)-76.67%

EPS NQ rev (1m)10.94%

EPS NQ rev (3m)31.6%

EPS NY rev (1m)8.76%

EPS NY rev (3m)-1288.24%

Revenue NQ rev (1m)-0.12%

Revenue NQ rev (3m)-2.57%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-1.5%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.69
P/FCF	N/A
P/OCF	N/A
P/B	0.81
P/tB	0.92
EV/EBITDA	N/A

EPS(TTM)-7.58

EYN/A

EPS(NY)-1.92

Fwd EYN/A

FCF(TTM)-6.7

FCFYN/A

OCF(TTM)-6.06

OCFYN/A

SpS0.89

BVpS1.85

TBVpS1.63

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-149.8%
ROE	-424.25%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-114.02%

ROA(5y)-88.4%

ROE(3y)-243.66%

ROE(5y)-173.09%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.17

Health

		Industry Rank	Sector Rank
Debt/Equity	0.97
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	104.13%
Cap/Sales	71.27%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.24
Quick Ratio	2.71
Altman-Z	-18.3

F-Score4

WACC7.97%

ROIC/WACCN/A

Cap/Depr(3y)311.89%

Cap/Depr(5y)350.75%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)36.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%77.68%

EPS Next Y77.15%

EPS Next 2Y37.06%

EPS Next 3Y25.67%

EPS Next 5Y15.44%

Revenue 1Y (TTM)219.67%

Revenue growth 3YN/A

Revenue growth 5Y21.66%

Sales Q2Q%128.07%

Revenue Next Year234.98%

Revenue Next 2Y190.44%

Revenue Next 3Y134%

Revenue Next 5Y80.94%

EBIT growth 1Y36.47%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year98.55%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y24.65%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y24.83%

OCF growth 3YN/A

OCF growth 5YN/A

BEYOND AIR INC / XAIR FAQ

What is the fundamental rating for XAIR stock?

ChartMill assigns a fundamental rating of 3 / 10 to XAIR.

What is the valuation status for XAIR stock?

ChartMill assigns a valuation rating of 1 / 10 to BEYOND AIR INC (XAIR). This can be considered as Overvalued.

How profitable is BEYOND AIR INC (XAIR) stock?

BEYOND AIR INC (XAIR) has a profitability rating of 0 / 10.

What is the expected EPS growth for BEYOND AIR INC (XAIR) stock?

The Earnings per Share (EPS) of BEYOND AIR INC (XAIR) is expected to grow by 77.15% in the next year.

BEYOND AIR INC (XAIR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BEYOND AIR INC / XAIR FAQ

What is the fundamental rating for XAIR stock?

What is the valuation status for XAIR stock?

How profitable is BEYOND AIR INC (XAIR) stock?

What is the expected EPS growth for BEYOND AIR INC (XAIR) stock?